Bontempo Ohly Capital Mgmt LLC Has $3.25 Million Holdings in CVS Health Co. (NYSE:CVS)

Bontempo Ohly Capital Mgmt LLC lifted its holdings in CVS Health Co. (NYSE:CVS) by 2.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 51,663 shares of the pharmacy operator’s stock after acquiring an additional 1,279 shares during the period. CVS Health makes up approximately 1.5% of Bontempo Ohly Capital Mgmt LLC’s investment portfolio, making the stock its 23rd largest position. Bontempo Ohly Capital Mgmt LLC’s holdings in CVS Health were worth $3,249,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Reston Wealth Management LLC bought a new position in CVS Health in the 3rd quarter valued at approximately $32,000. First Community Trust NA raised its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new position in CVS Health in the 3rd quarter valued at approximately $33,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 2.8 %

Shares of NYSE CVS opened at $55.29 on Friday. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm’s 50 day simple moving average is $59.32 and its two-hundred day simple moving average is $58.78. The stock has a market capitalization of $69.58 billion, a P/E ratio of 14.03, a PEG ratio of 0.99 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter last year, the business earned $2.21 earnings per share. The business’s revenue was up 6.3% on a year-over-year basis. As a group, analysts expect that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.81%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is 67.51%.

Analyst Ratings Changes

Several research analysts have issued reports on CVS shares. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Mizuho lowered their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Piper Sandler lowered their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. UBS Group boosted their price objective on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Finally, Royal Bank of Canada decreased their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $70.50.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.